南方医药创新股票C(010593)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
1,235,550,000 |
1,195,950,000 |
51,443,200 |
91,034,900 |
-39,591,700 |
-3.2% |
2023/12/31 |
1,357,690,000 |
1,235,550,000 |
279,874,000 |
402,020,000 |
-122,146,000 |
-9% |
2023/12/31 |
1,280,280,000 |
1,235,550,000 |
39,434,100 |
84,166,400 |
-44,732,300 |
-3.49% |
2023/9/30 |
1,278,440,000 |
1,280,280,000 |
90,540,900 |
88,708,200 |
1,832,700 |
0.14% |
2023/6/30 |
1,357,690,000 |
1,278,440,000 |
149,899,000 |
229,145,000 |
-79,246,000 |
-5.84% |
2023/6/30 |
1,292,760,000 |
1,278,440,000 |
67,312,700 |
81,623,800 |
-14,311,100 |
-1.11% |
2023/3/31 |
1,357,690,000 |
1,292,760,000 |
82,586,200 |
147,521,000 |
-64,934,800 |
-4.78% |
2022/12/31 |
1,235,900,000 |
1,357,690,000 |
843,395,000 |
721,600,000 |
121,795,000 |
9.85% |
2022/12/31 |
1,450,650,000 |
1,357,690,000 |
109,768,000 |
202,723,000 |
-92,955,000 |
-6.41% |
2022/9/30 |
1,322,150,000 |
1,450,650,000 |
263,275,000 |
134,775,000 |
128,500,000 |
9.72% |
2022/6/30 |
1,235,900,000 |
1,322,150,000 |
470,352,000 |
384,102,000 |
86,250,000 |
6.98% |
2022/6/30 |
1,309,130,000 |
1,322,150,000 |
177,339,000 |
164,323,000 |
13,016,000 |
0.99% |
2022/3/31 |
1,235,900,000 |
1,309,130,000 |
293,013,000 |
219,779,000 |
73,234,000 |
5.93% |
2021/12/31 |
1,287,160,000 |
1,235,900,000 |
718,347,000 |
769,607,000 |
-51,260,000 |
-3.98% |
2021/12/31 |
1,015,680,000 |
1,235,900,000 |
376,745,000 |
156,530,000 |
220,215,000 |
21.68% |
2021/9/30 |
974,147,000 |
1,015,680,000 |
294,016,000 |
252,482,000 |
41,534,000 |
4.26% |
2021/6/30 |
1,287,160,000 |
974,147,000 |
47,586,300 |
360,595,000 |
-313,008,700 |
-24.32% |
2021/6/30 |
1,287,160,000 |
974,147,000 |
47,586,300 |
360,595,000 |
-313,008,700 |
-24.32% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。